Best Compounds for Skin & Hair: Evidence-Based Rankings
Healthy skin and hair are markers of overall wellness that most people actively pursue. Whether you're concerned about aging, hair loss, inflammatory conditions, or general appearance, the supplement market offers hundreds of options—many with minimal scientific support. However, a growing body of clinical research has identified specific compounds with measurable, reproducible benefits supported by rigorous human trials.
This guide ranks the most effective compounds for skin and hair health based on the strength of clinical evidence. We've excluded unproven ingredients and focused exclusively on compounds with peer-reviewed human studies demonstrating meaningful improvements in measurable outcomes.
Why Evidence-Based Selection Matters
The supplement industry generates billions in revenue annually, yet most products lack robust clinical validation. Marketing often relies on animal studies, test-tube research, or anecdotal reports rather than human trials. This creates a gap between what's promoted and what actually works.
Choosing evidence-based compounds protects both your wallet and your health. Strong clinical evidence means:
- Reproducible results: Multiple independent studies show consistent improvements
- Measurable outcomes: Improvements in skin hydration, wrinkle depth, hair density, or disease severity scores—not vague claims
- Known safety profiles: Established dosing ranges and documented side effects from human research
- Cost-effectiveness: Investing in compounds proven to work at specific doses
The compounds below are ranked by evidence tier, from strongest (Tier 4) to probable (Tier 3) efficacy based on the quality and quantity of human clinical research.
Tier 4: Strongest Clinical Evidence
Collagen Peptides (Hydrolyzed Collagen)
What it is: Collagen peptides are short-chain amino acid fragments derived from animal collagen (typically bovine or fish). Unlike whole collagen protein, hydrolyzed collagen has a low molecular weight, making it highly absorbable when consumed orally.
The evidence: A meta-analysis of 19 randomized controlled trials involving 1,125 participants aged 20-70 years confirmed statistically significant improvements in skin hydration, elasticity, and wrinkle reduction with supplemental hydrolyzed collagen compared to placebo. Effects were observed across multiple skin aging parameters, with consistent results even accounting for study heterogeneity.
Key findings:
- Significant improvements in skin hydration across all age groups
- Measurable increases in skin elasticity
- Clinically meaningful wrinkle reduction
- Benefits observed within 8-12 weeks of consistent supplementation
Typical dosage: 10-20 grams daily, divided into 1-2 doses. Most studies showing benefits used 10-15 g/day.
Cost: $20-40 monthly for quality collagen peptides. Bioavailability varies by brand; look for hydrolyzed collagen with a molecular weight below 5,000 Daltons.
Important note: Evidence is strongest in women; fewer studies have examined men. Benefits are also most robust for skin aging parameters rather than other conditions.
Probiotics (Specific Strains for Skin Conditions)
What it is: Probiotics are live beneficial bacteria that support gut and skin health. For skin conditions, certain strains (particularly Lactobacillus and Bifidobacterium species) have demonstrated therapeutic effects.
The evidence: A meta-analysis of 5 randomized controlled trials with 286 participants found that probiotics produced clinically meaningful reductions in psoriasis severity. The pooled standardized mean difference (SMD) for Psoriasis Area and Severity Index (PASI) scores was -1.40, indicating substantial improvement. Participants receiving probiotics were 4.80 times more likely to achieve a 75% improvement in PASI scores compared to placebo.
Key findings:
- PASI score reduction of SMD -1.40 (95% CI -2.63 to -0.17)
- PASI 75 response rate: 4.80 times higher with probiotics vs. placebo
- Consistent benefits in both adults and infants with atopic dermatitis
- Improvements in quality of life measures alongside disease severity reduction
Typical dosage: 10-50 billion CFU daily, using multi-strain formulations or strain-specific products (Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium longum).
Cost: $15-35 monthly for quality probiotic supplements. Clinical-grade formulations often cost more but show better stability and higher CFU counts.
Conditions with strongest evidence: Psoriasis and atopic dermatitis.
Pycnogenol (French Maritime Pine Bark Extract)
What it is: Pycnogenol is a standardized extract from French maritime pine bark containing proanthocyanidins and other polyphenolic compounds. It's both an oral supplement and a topical ingredient.
The evidence: Multiple randomized controlled trials demonstrate strong clinical efficacy for hair density, skin elasticity, hydration, and photoaging markers. The evidence is supported by both clinical outcomes and molecular markers showing increased collagen and hyaluronic acid expression.
Key findings:
- Hair density increased 30% after 2 months of supplementation
- Hair density remained elevated at 23% improvement after 6 months
- Improvements in skin elasticity and hydration
- Reductions in photoaging markers
- Effects observed in menopausal women (n=76, double-blind RCT design)
Typical dosage: 100-150 mg daily for hair and skin benefits. The most robust results used 150 mg/day.
Cost: $25-50 monthly. Pycnogenol is a patented ingredient, so standardized products (look for "Pycnogenol™" on labels) may cost more than generic pine bark extracts.
Timeline: Results typically emerge within 4-8 weeks, with continued improvement at 12-24 weeks.
Tier 3: Probable Clinical Evidence
These compounds show clinically meaningful benefits in human studies but have limitations: smaller sample sizes, shorter durations, or limited independent replication. They remain well-supported compared to most supplements.
Ashwagandha
What it is: Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic medicine containing withanolides, active compounds with anti-inflammatory and stress-modulating properties.
The evidence: Multiple human randomized controlled trials demonstrate improvements in hair density, hair growth metrics, and skin hydration. However, studies are limited by small sample sizes and short durations (60-75 days), with insufficient independent replication.
Key findings:
- Oral ashwagandha (300 mg twice daily for 75 days) significantly improved hair density
- Increased hair growth and anagen-to-telogen ratios (measures of hair health)
- Reduced transepidermal water loss (a measure of skin hydration)
- Improvements in dermatology-specific quality of life (DLQI, p<0.05)
Typical dosage: 300 mg twice daily (600 mg total daily). Studies showing benefits used this dosing protocol.
Cost: $10-25 monthly for quality ashwagandha extracts.
Strength limitations: Evidence is probable rather than confirmed due to small study sizes and lack of independent research group replication.
Melanotan-1 (Afamelanotide)
What it is: Melanotan-1 is a synthetic peptide that activates melanocortin-1 receptors, promoting melanin production and skin pigmentation. It's approved in some regions for treating vitiligo and photosensitivity disorders.
The evidence: Multiple human studies consistently show enhanced skin pigmentation and photoprotection. However, evidence is limited to small-to-moderate sample sizes and primarily addresses medical treatment rather than cosmetic enhancement.
Key findings:
- Enhanced tanning maintained at least 3 weeks longer than sunlight-only controls
- 47% reduction in sunburn cells at irradiated sites
- Consistent positive results across multiple human studies
- Applications primarily in vitiligo and photosensitivity management
Typical dosage: Varies by formulation and condition; pharmaceutical versions require medical supervision.
Cost: Varies widely; prescription formulations are medical treatments rather than over-the-counter supplements.
Important note: Evidence for cosmetic hair and skin enhancement is more limited than for disease treatment.
Cerebrolysin
What it is: Cerebrolysin is a neuropeptide complex derived from porcine brain tissue, traditionally used for neurological conditions.
The evidence: An observational case series (n=5) reported hair repigmentation in patients receiving cerebrolysin for neurologic conditions. Mechanistic evidence shows reactivation of melanocyte markers, but evidence is very limited.
Key findings:
- Macroscopic diffuse darkening of scalp hair observed in 5 patients (mean age 70.6 years)
- Evidence limited to single observational study with no placebo control or independent replication
- Mechanistic support for melanocyte reactivation
Typical dosage: 10-30 mL parenteral (injection) formulations, typically administered in clinical settings.
Cost: Highly variable; primarily available through medical providers.
Strength limitations: Only one small observational human study; no RCTs or independent replication. Should be considered highly preliminary.
GLP-1 Receptor Agonists
What it is: GLP-1 receptor agonists are peptide medications (including semaglutide and other agents) that activate glucagon-like peptide-1 receptors, primarily used for diabetes and weight management.
The evidence: Multiple observational studies and small randomized controlled trials suggest benefits for inflammatory skin conditions through anti-inflammatory mechanisms. However, evidence is limited by small sample sizes, short durations, and mixed findings on hair loss and facial aging.
Key findings:
- Semaglutide reduced psoriasis severity (PASI score) from median 21 to 10 over 12 weeks
- Benefits observed in 31 obese type 2 diabetes patients (p=0.002)
- Probable anti-inflammatory effects on skin conditions
- Mixed evidence regarding hair loss and facial aging effects
Typical dosage: Prescription medications; dosing varies by indication (typically 0.5-2.4 mg weekly for approved uses).
Cost: Highly variable; typically $200-400 monthly without insurance; covered for FDA-approved indications.
Important note: Primary use is diabetes and weight management; skin benefits are secondary observations.
NAC (N-Acetylcysteine)
What it is: NAC is a modified amino acid precursor to glutathione, a master antioxidant involved in cellular detoxification and health.
The evidence: NAC shows probable efficacy for body-focused repetitive behaviors (trichotillomania and dermatillomania/skin-picking) and wound healing. Evidence is moderate but limited by small human sample sizes.
Key findings:
- Identified as "most impressive adjunctive therapy" for trichotillomania when combined with SSRIs and behavioral therapy
- Systematic review of 23 articles supporting effectiveness for hair-pulling behaviors
- Benefits for wound healing in animal models and limited human studies
Typical dosage: 1,200-2,400 mg daily in divided doses for trichotillomania; 600-1,200 mg daily for general health.
Cost: $10-20 monthly for NAC supplements.
Strength limitations: Evidence is strongest for behavioral dermatological conditions rather than primary skin health or hair loss prevention.
Zinc
What it is: Zinc is an essential mineral critical for immune function, protein synthesis, and skin barrier integrity.
The evidence: Zinc supplementation shows probable efficacy for acne and alopecia areata, with consistent evidence that affected patients have lower serum zinc levels. However, human evidence comes primarily from small randomized controlled trials and observational studies.
Key findings:
- Acne patients have significantly lower serum zinc levels versus controls
- Zinc supplementation reduced inflammatory papule counts significantly versus untreated controls
- Consistent evidence across 6+ randomized controlled trials (meta-analysis)
- Benefits observed in alopecia areata, particularly when zinc levels are deficient
Typical dosage: 15-30 mg elemental zinc daily for skin and hair health. Higher doses (50+ mg) may cause nausea and copper imbalance with long-term use.
Cost: $5-15 monthly for quality zinc supplements.
Strength limitations: Evidence is strongest when patients are zinc-deficient; benefits in zinc-replete individuals are less certain.
Curcumin
What it is: Curcumin is the primary polyphenolic compound in turmeric (Curcuma longa), with potent anti-inflammatory and antioxidant properties.
The evidence: Curcumin shows probable efficacy for skin health, particularly inflammatory conditions like pruritus and psoriasis, supported by 3 human randomized controlled trials and 2 systematic reviews.
Key findings:
- Curcumin (1 g/day for 4 weeks) significantly reduced pruritus severity scores (p<0.001)
- Quality of life improvements measured by DLQI in 96 participants
- Benefits for inflammatory skin conditions
- Limited by small sample sizes and short study durations
Typical dosage: 500-1,000 mg daily, often with black pepper extract (piperine) to improve absorption. Standard curcumin has poor bioavailability without absorption enhancers.
Cost: $15-30 monthly for bioavailable curcumin formulations.
Strength limitations: Evidence limited to 3 human RCTs with modest sample sizes; inconsistent methodologies across trials.
Resveratrol
What it is: Resveratrol is a polyphenol found in grape skin, berries, and wine with antioxidant and anti-aging properties.
The evidence: Three human randomized controlled trials demonstrate improvements in wrinkle reduction, skin elasticity, and aging markers, but evidence remains limited by small sample sizes and short durations.
Key findings:
- Oral (75 mg) and topical (1.5%) trans-resveratrol significantly reduced wrinkle scores after 8 weeks
- Benefits observed in healthy females aged 40+ (n=122, double-blind design)
- Improvements in skin elasticity and aging markers
- Limited by small number of studies and inconsistent methodologies
Typical dosage: 150-500 mg daily oral; topical products contain 0.5-2% resveratrol.
Cost: $20-40 monthly for oral supplements; topical products vary ($20-60 per bottle).
Strength limitations: Only 3 human studies; modest sample sizes; inconsistent measurement approaches.
CoQ10 (Ubiquinone/Ubiquinol)
What it is: CoQ10 is a fat-soluble antioxidant and electron carrier essential for cellular energy production (ATP synthesis).
The evidence: One well-designed randomized controlled trial demonstrated reduced wrinkles and improved skin smoothness, but evidence remains limited to a small number of human studies.
Key findings:
- Oral CoQ10 (50-150 mg daily for 12 weeks) significantly reduced visible wrinkles and microrelief lines
- Improved skin smoothness in healthy subjects (n=33, double-blind design)
- No significant effect on skin hydration or dermis thickness
- Benefits limited to wrinkle reduction and texture
Typical dosage: 50-150 mg daily; ubiquinol (reduced form) has superior bioavailability compared to ubiquinone.
Cost: $15-35 monthly for quality CoQ10 supplements.
Strength limitations: Evidence limited to one primary study with modest sample size (n=33).
Melatonin
What it is: Melatonin is an endogenous hormone produced by the pineal gland, involved in sleep regulation and antioxidant defense.
The evidence: Three human randomized controlled trials demonstrate improvements in atopic dermatitis severity and sleep quality. Mechanistic evidence from animal studies supports skin and hair health benefits.
Key findings:
- Melatonin 10 mg/day for 4 weeks in atopic dermatitis patients significantly reduced SCORAD disease severity (p<0.001)
- Reduced pruritus-NRS scores (p=0.006)
- Improved sleep quality (ADSS, p<0.05)
- Quality of life improvements (DLQI, p=0.003)
Typical dosage: 3-10 mg daily in the evening; higher doses (20-50 mg) used in some studies with no additional benefit.
Cost: $5-15 monthly for melatonin supplements.
Strength limitations: Limited independent replication for hair loss specifically; evidence strongest for atopic dermatitis.
Milk Thistle (Silymarin)
What it is: Milk thistle (Silybum marianum) seed extract contains silymarin, a flavonolignan complex with hepatoprotective and anti-inflammatory properties.
The evidence: Two human randomized controlled trials and 4 observational studies demonstrate effects on vitiligo repigmentation, acne severity, and UV-induced skin damage.
Key findings: